They showed a higher recovery of EpCAMlow tumor cell using SCLC cell lines with high and low EpCAM expression and a higher CTC count using the label-independent Parsortix device compared to the EpCAM-based CellSearch system in all 12 patients’ samples [24]. The gene discussed is EPCAM; the disease is neoplasm.